Predictors of treatment failures during chemotherapy: A prospective study on 110 older cancer patients

Archives of Gerontology and Geriatrics

Volumn 48, Issue 2, 2009, Pages 222-226

  Marinello, Renata ^a   Marenco, Daniela ^b   Roglia, Daniela ^a   Stasi, Maria Francesca ^a   Ferrando, Alberto ^b   Ceccarelli, Manuela ^b   Bertetto, Oscar ^b   Molaschi, Mario ^a   Ciccone, Giovannino ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

Author keywords

Chemotherapy toxicity; Comorbidity; Comprehensive geriatric assessment; Performance status; Treatment failure

Indexed keywords

ANTHRACYCLINE; ANTIINFECTIVE AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; FLUOROFOLIC ACID; FLUOROURACIL; GEMCITABINE; METHOTREXATE; NAVELBINE; OXALIPLATIN; PACLITAXEL; UNCLASSIFIED DRUG;

AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; COLON CANCER; COMORBIDITY; DAILY LIFE ACTIVITY; FEMALE; HEALTH SURVEY; HUMAN; KARNOFSKY PERFORMANCE STATUS; LUNG CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TREATMENT FAILURE; UNSPECIFIED SIDE EFFECT;

ACTIVITIES OF DAILY LIVING; AGE FACTORS; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMORBIDITY; FEMALE; GERIATRIC ASSESSMENT; HUMANS; KARNOFSKY PERFORMANCE STATUS; MALE; NEOPLASMS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; TREATMENT FAILURE;

EID: 58349111900     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archger.2008.01.011     Document Type: Article

References (30)

1. Balducci L. Geriatric oncology: challenges for the new century. Eur. J. Cancer 36 (2000) 1741-1754
2. Balducci L., and Corcoran M.B. Antineoplastic chemotherapy of the older cancer patient. Hematol. Oncol. Clin. North Am. 14 (2000) 193-212
3. Balducci L., and Extermann M. Management of cancer in the older person: a practical approach. Oncologist 5 (2000) 224-237
4. Begg C.B., Cohen J.L., and Ellerton J. Are the elderly predisposed to toxicity from cancer chemotherapy? An investigation using data from the Eastern Cooperative Oncology Group. Cancer Clin. Trials 3 (1980) 369-374
5. Biganzoli L., Goldhirsch A., Straehle C., Castiglione-Gertsch M., Therasse P., Aapro M., Minisini A., and Piccart M.J. Adjuvant chemotherapy in elderly patients with breast cancer: a survey of the Breast International Group (BIG). Ann. Oncol. 15 (2004) 207-210
6. Chen H., Cantor A., Meyer J., Beth Corcoran M., Grendys E., Cavanaugh D., Antonek S., Camarata A., Haley W., Balducci L., and Extermann M. Can older cancer patients tolerate chemotherapy? A prospective pilot study. Cancer 97 (2003) 1107-1114
7. Chen C.C., Kenefick A.L., Tang S.T., and McCorkle R. Utilization of comprehensive geriatric assessment in cancer patients. Crit. Rev. Oncol. Hematol. 49 (2004) 53-67
8. Cohen H.J. Geriatric principles of treatment and applied to medical oncology: an overview. Semin. Oncol. 22 (1995) 1-2
9. Crivellari D., Bonetti M., Castiglione-Gertsch M., Gelber R.D., Rudenstam C.M., Thürlimann B., Price K.N., Coates A.S., Hürny C., Bernhard J., Lindtner J., Collins J., Senn H.J., Cavalli F., Forbes J., Gudgeon A., Simoncini E., Cortes-Funes H., Veronesi A., Fey M., and Goldhirsch A. Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII. J. Clin. Oncol. 18 (2000) 1412-1422
10. Extermann M., and Aapro M. Assessment of the older cancer patient. Hematol. Oncol. Clin. North Am. 14 (2000) 63-77
11. Extermann M., Overcash J., Lyman G.H., Parr J., and Balducci L. Comorbidity and functional status are independent in older cancer patients. J. Clin. Oncol. 16 (1998) 1582-1587
12. Extermann M., Chen H., Cantor A.B., Corcoran M.B., Meyer J., Grendys E., Cavanaugh D., Antonek S., Camarata A., Haley W.E., and Balducci L. Predictors of tolerance to chemotherapy in older cancer patients: a prospective pilot study. Eur. J. Cancer 38 (2002) 1466-1473
13. Ferrucci L., Guralnik J.M., Cavazzini C., Bandinelli S., Lauretani F., Bartali B., Repetto L., and Longo D.L. The frailty syndrome: a critical issue in geriatric oncology. Crit. Rev. Oncol. Hematol. 46 (2003) 127-137
14. Freyer G., Lortholary A., Delcambre C., Delozier T., Piot G., Genin F., and Pujade-Lauraine E. Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens. Unexpected toxicities in elderly patients treated with oral idarubicin in metastatic breast cancer: the GINECO experience. Clin. Oncol. 16 (2004) 17-23
15. Karnofsky D.A., Abelman W.H., and Craver L.F. The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer 1 (1948) 634
16. Katz S., Ford A.B., Moskowitz R.W., Jackson B.A., and Jaffe M.W. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. J. Am. Med. Assoc. 185 (1963) 94-99
17. Langer C.J., Manola J., Bernardo P., Kugler J.W., Bonomi P., Cella D., and Johnson D.H. Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial. J. Natl. Cancer Inst. 94 (2002) 173-181
18. Lawton M.P., and Brody E.M. Assessment of older people: self maintaining and instrumental activities of daily living. Gerontologist 9 (1969) 179-186
19. Linn B.S., Linn M.W., and Gurrel L. Cumulative illness rating scale. J. Am. Geriatr. Soc. 16 (1968) 622-627
20. Monfardini S., Ferrucci L., Fratino L., Del Lungo I., Serraino D., and Zagonel V. Validation of a multidimensional evaluation scale for use in elderly cancer patients. Cancer 77 (1996) 395-401
21. Oken M.M., Creech R.H., Tormey D.C., Horton J., Davis T.E., McFadden E.T., and Carbone P.P. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am. J. Clin. Oncol. 5 (1982) 649-655
22. Overcash J. The case for a geriatric oncology program in a cancer center. In: Balducci L., Lyman G., and Ersher W.B. (Eds). Comprehensive Geriatric Oncology (1998), Harward Academic Publishers, London 813-824
23. Pfeiffer E. A Short Portable Mental Status Questionnaire for the assessment of organic brain deficit in elderly patients. J. Am. Geriatr. Soc. 23 (1975) 443-449
24. Piccirillo J.F., Tierney R.M., Costas I., Grove L., and Spitznagel Jr. E.L. Prognostic importance of comorbidity in a hospital-based cancer registry. J. Am. Med. Assoc. 291 (2004) 2441-2447
25. Repetto L., Fratino L., Audisio R.A., Venturino A., Gianni W., Vercelli M., Parodi S., Dal Lago D., Gioia F., Monfardini S., Aapro M.S., Serraino D., and Zagonel V. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J. Clin. Oncol. 20 (2002) 494-502
26. Repetto L., Venturino A., Fratino L., Serraino D., Troisi G., Gianni W., and Pietropaolo M. Geriatric oncology: a clinical approach to the older patient with cancer. Eur. J. Cancer 39 (2003) 870-880
27. Reuben D.B., Wieland D.L., and Rubenstein L.Z. Functional status assessment of older persons: concepts and implications. Facts Res. Gerontol. 7 (1993) 231-240
28. Sargent D.J., Goldberg R.M., Jacobson S.D., Macdonald J.S., Labianca R., Haller D.G., Shepherd L.E., Seitz J.F., and Francini G. A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N. Engl. J. Med. 345 (2001) 1091-1097
29. Watters J.M., Yau J.C., O'Rourke K., Tomiak E., and Gertler S.Z. Functional status is well maintained in older women during adjuvant chemotherapy for breast cancer. Ann. Oncol. 14 (2003) 1744-1750
30. Yancik R., Wesley M.N., Ries L.A., Havlik R.J., Long S., Edwards B.K., and Yates J.W. Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study. Cancer 82 (1998) 2123-2134